3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Head and Neck Neoplasms
22
Squamous Cell Carcinoma of Head and Neck
19
Melanoma
10
Uterine Cervical Neoplasms
9
Anus Neoplasms
8
Ovarian Neoplasms
7
Neoplasm Metastasis
7
Carcinoma, Non-Small-Cell Lung
7
Nasopharyngeal Carcinoma
6
Vaginal Neoplasms
5
Thyroid Neoplasms
5
Stomach Neoplasms
5
Penile Neoplasms
5
Oropharyngeal Neoplasms
5
Neoplasms
5
Carcinoma, Renal Cell
5
Breast Neoplasms
5
Recurrence
4
Pancreatic Neoplasms
4
Esophageal Neoplasms
4
Carcinoma, Transitional Cell
4
Carcinoma, Squamous Cell
4
Carcinoma, Merkel Cell
4
Carcinoma, Hepatocellular
4
Vulvar Neoplasms
3
Triple Negative Breast Neoplasms
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Mouth Neoplasms
3
Lung Neoplasms
3
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Nivolumab
2
Biopsy
2
trastuzumab deruxtecan
1
sargramostim
1
pembrolizumab
1
ceralasertib
1
belinostat
1
X-Rays
1
Ipilimumab
1
Immunoglobulin G
1
Fluorouracil
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
Cyclophosphamide
×
Head & Neck
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled